Heterogeneity of biochemical dysfunction in Gilles de la Tourette syndrome (GTS)

Author： Pourcher E.   Bouchard R.H.   Rouillard C.   Beacute dard P.J.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 390-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dronabinol appears to reduce tics in patients with Gilles de la Tourette's syndrome

By  

Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Benzatropine: Esotropia (first report) and mydriasis in a patient with pseudohypoparathyroidism, mental retardation and Gilles de la Tourette's syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Emerging drugs in Tourette syndrome

By Silay Yavuz S   Jankovic Joseph  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 365-380

Informa Healthcare

Access to resources Recommend Favorite

Tourette's Syndrome and Role of Tetrabenazine: Review and Personal Experience

By Porta Mauro   Sassi Marco   Cavallazzi Mario   Fornari Maurizio   Brambilla Arianna   Servello Domenico  

Clinical Drug Investigation, Vol. 28, Iss. 7, 2008-01 ,pp. : 443-459

Adis International

Access to resources Recommend Favorite

Tourette Syndrome: Clinical Characteristics and Current Management Strategies

By Kossoff E.H.   Singer H.S.  

Pediatric Drugs, Vol. 3, Iss. 5, 2001-01 ,pp. : 355-363

Adis International

Access to resources Recommend Favorite